Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1140120110160020134
Cancer Prevention Research
2011 Volume.16 No. 2 p.134 ~ p.140
Luteolin Down-Regulates ErbB3 Signaling Pathway in HT-29 Human Colon Cancer Cells
Lim Do-Young

Cho Han-Jin
Park So-Young
Lee Ki-Won
Yoon Jung-Han
Abstract
Luteolin is 3¡¯,4¡¯,5,7-tetrahydroxyflavone found in various kind of fruits and vegetables. We have previously shown that luteolin decreased HT-29 cell growth by inducing apoptosis and cell cycle arrest. The present study examined whether luteolin downregulates ErbB3 signaling pathway in HT-29 cells. Cells were cultured with or without 60¥ìmol/L of luteolin and/or heregulin (HRG)-¥â. HRG-¥â induced proliferation of HT-29 cells and luteolin abrogated this induction. Luteolin decreased both protein and mRNA levels of EGFR, ErbB3 and ErbB2 in HT-29 cells. Immunoprecipitation/Western blot analyses revealed that luteolin decreased HRG-¥â-induced tyrosine phosphorylation of ErbB3, recruitment of the p85 subunit of PI3K to ErbB3, and ErbB3-associated PI3K activity. Furthermore luteolin decreased HRG-¥â-stimulated phosphorylation of Akt. Luteolin also decreased extracellular signal-regulated kinase (ERK)1/2. The present results demonstrate that luteolin down-regulates the ErbB3 signaling pathway, which may one of the mechanisms responsible for the growth inhibitory effect on HT-29 cells.
KEYWORD
Luteolin, Colon cancer, ErbB3, Phosphatidylinositol 3-kinase (PI3K), Akt
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) ´ëÇÑÀÇÇÐȸ ȸ¿ø